“In the minds of the progressive Democrats who run” Los Angeles and California, “ICE efforts to arrest and deport those who have entered the country illegally are unpopular among their ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Apple shares rose slightly Tuesday after losing ground the previous session following ...

The team that won the offseason again still finds gaining respect difficult. Perhaps it's partly because the Bears annually make a habit of building their roster up to the point where they're ...

Consumer group Choice tested 20 sunscreens and found only four provided the SPF protection their label claimed. The brands dispute the findings and say their own testing shows their sunscreens ...

However, fans were quick to point out that it was an editing fail, as there were four women on Jack's farm at the end of the previous episode. Fans also noted that there were four wine glasses on ...

External SSDs under 256GB are about twice as likely to fail as those over 4TB. This is attributed to similar factors: frequent use, fewer flash chips, and less advanced controllers. “Small ...

Seth Rollins became a two-time Mr. Money in the Bank last weekend in Los Angeles. While the contract substantially increases The Visionary's odds of being a champion in the future, it doesn't ...

The TSA has issued a warning to travelers about foods that could be confiscated before getting on board a flight. The official travel administration recently shared a post to X (formerly Twitter ...

ROME — The fear that four-time champion Italy will fail to qualify for a third straight World Cup has cost coach Luciano Spalletti his job. Spalletti announced Sunday that he is being fired ...

Midfielder George Saville and goalkeeper Liam Roberts are to leave Millwall at the end of the month after both failed to agree a new contracts with the club. Saville made almost 250 appearances ...

Acadia Pharma’s plan to develop pimavanserin as a treatment for additional indications is in disarray after the drug failed a phase 3 trial in schizophrenia. The company said it doesn’t intend ...

Embed <iframe src="https://www.npr.org/player/embed/nx-s1-5428177/nx-s1-5488506-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio ...